S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14

Rite Aid (RAD) Stock Forecast, Price & News

-0.47 (-7.76%)
(As of 05/18/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
4.03 million shs
Average Volume
3.51 million shs
Market Capitalization
$311.07 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive RAD News and Ratings via Email

Sign-up to receive the latest news and ratings for Rite Aid and its competitors with MarketBeat's FREE daily newsletter.

Rite Aid logo

About Rite Aid

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and general merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. In addition, this segment offers healthcare coaching and disease management services to health plans and employers. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. As of February 26, 2022, the company operated 2,450 retail pharmacy locations in 17 states. Rite Aid Corporation was founded in 1962 and is headquartered in Camp Hill, Pennsylvania.


Rite Aid Stock is Getting Cheap Enough to Buy Here
Drugstore operator Rite Aid Corporation (NYSE: RAD) stock has been pummeled since hitting a post-pandemic high of $32.48 on Jan. 28, 2021.
Rite Aid Wants to Help Children Get Medical Care
See More Headlines

Industry, Sector and Symbol

Drug stores & proprietary stores
Drug Retail
Year Founded

Sales & Book Value

Annual Sales
$24.57 billion
Cash Flow
$7.76 per share
Book Value
$1.78 per share


Net Income
$-538.48 million
Pretax Margin




Free Float
Market Cap
$311.07 million

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Social Links


Overall MarketRank

1.71 out of 5 stars

Retail/Wholesale Sector

204th out of 284 stocks

Drug Stores & Proprietary Stores Industry

7th out of 9 stocks

Analyst Opinion: 2.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Rite Aid (NYSE:RAD) Frequently Asked Questions

Is Rite Aid a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last twelve months. There are currently 3 sell ratings for the stock. The consensus among Wall Street research analysts is that investors should "sell" Rite Aid stock.
View analyst ratings for Rite Aid
or view top-rated stocks.

When is Rite Aid's next earnings date?

Rite Aid is scheduled to release its next quarterly earnings announcement on Thursday, June 23rd 2022.
View our earnings forecast for Rite Aid

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) posted its quarterly earnings data on Thursday, April, 14th. The company reported ($1.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.57) by $1.06. The business had revenue of $6.07 billion for the quarter, compared to the consensus estimate of $5.96 billion. Rite Aid had a negative trailing twelve-month return on equity of 19.38% and a negative net margin of 2.19%. Rite Aid's revenue for the quarter was up 2.5% compared to the same quarter last year. During the same period last year, the business posted ($0.78) earnings per share.
View Rite Aid's earnings history

When did Rite Aid's stock split? How did Rite Aid's stock split work?

Rite Aid's stock reverse split before market open on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split.

What guidance has Rite Aid issued on next quarter's earnings?

Rite Aid updated its FY23 earnings guidance on Thursday, April, 14th. The company provided EPS guidance of ($1.06)-($0.53) for the period, compared to the consensus estimate of ($1.22). The company issued revenue guidance of $23.1-23.5 billion, compared to the consensus revenue estimate of $23.44 billion.

What price target have analysts set for RAD?

3 Wall Street analysts have issued twelve-month price objectives for Rite Aid's stock. Their forecasts range from $2.00 to $12.00. On average, they anticipate Rite Aid's share price to reach $8.33 in the next twelve months. This suggests a possible upside of 49.1% from the stock's current price.
View analysts' price targets for Rite Aid
or view top-rated stocks among Wall Street analysts.

Who are Rite Aid's key executives?
Rite Aid's management team includes the following people:
  • Ms. Heyward Rutledge Donigan B.A., Pres, CEO & Director (Age 61, Pay $2.18M)
  • Mr. Matthew C. Schroeder, CFO & Exec. VP (Age 52, Pay $1.17M)
  • Mr. Justin L. Mennen, Chief Technology & Digital Officer (Age 41, Pay $731.15k)
  • Mr. Brian T. Hoover, Chief Accounting Officer & Sr. VP (Age 57)
  • Byron Purcell, Sr. Director of Treasury Services & Investor Relations
  • Mr. Trent Kruse, Sr. VP of Investor Relations & Treasury
  • Mr. Paul D. Gilbert, Exec. VP, Gen. Counsel & Corp. Sec. (Age 55)
  • Ms. Susan K. Henderson, Chief Communications Officer & Sr. VP (Age 69)
  • Mr. Frank G. Vitrano, Chief Strategic Bus. Devel. Officer (Age 67)
  • Ms. Jessica Kazmaier, Exec. VP & Chief HR Officer (Age 44)
What is Heyward Donigan's approval rating as Rite Aid's CEO?

169 employees have rated Rite Aid CEO Heyward Donigan on Glassdoor.com. Heyward Donigan has an approval rating of 58% among Rite Aid's employees. This puts Heyward Donigan in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Rite Aid own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), (CELG), Bank of America (BAC), Akorn (AKRX), Advanced Micro Devices (AMD), Cleveland-Cliffs (CLF), Mr. Cooper Group (COOP), General Electric (GE), Micron Technology (MU) and CVS Health (CVS).

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

Who are Rite Aid's major shareholders?

Rite Aid's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (10.10%), BlackRock Inc. (8.84%), Invesco Ltd. (5.03%), Dimensional Fund Advisors LP (3.14%), State Street Corp (3.04%) and JPMorgan Chase & Co. (1.94%). Company insiders that own Rite Aid stock include Heyward R Donigan and Jocelyn Z Konrad.
View institutional ownership trends for Rite Aid

Which major investors are selling Rite Aid stock?

RAD stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., UBS Group AG, Group One Trading L.P., State Street Corp, Walleye Capital LLC, Citigroup Inc., Simplex Trading LLC, and Bank of New York Mellon Corp.
View insider buying and selling activity for Rite Aid
or view top insider-selling stocks.

Which major investors are buying Rite Aid stock?

RAD stock was acquired by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Vanguard Group Inc., JPMorgan Chase & Co., BlackRock Inc., Federated Hermes Inc., PDT Partners LLC, Renaissance Technologies LLC, and Engineers Gate Manager LP.
View insider buying and selling activity for Rite Aid
or or view top insider-buying stocks.

How do I buy shares of Rite Aid?

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Rite Aid's stock price today?

One share of RAD stock can currently be purchased for approximately $5.59.

How much money does Rite Aid make?

Rite Aid has a market capitalization of $311.07 million and generates $24.57 billion in revenue each year. The company earns $-538.48 million in net income (profit) each year or ($9.95) on an earnings per share basis.

How many employees does Rite Aid have?

Rite Aid employs 53,000 workers across the globe.

Does Rite Aid have any subsidiaries?

The following companies are subsidiares of Rite Aid: 1515 West State Street Boise Idaho LLC, 1740 Associates LLC, 4042 Warrensville Center Road—Warrensville Ohio Inc., 5277 Associates Inc., 5600 Superior Properties Inc., Advance Benefits LLC, Apex Drug Stores Inc., Ascend Health Technology LLC, Bartell Drugs, Broadview and Wallings—Broadview Heights Ohio Inc., Design Rx Holdings LLC, Design Rx LLC, Design Rxclusives LLC, Drug Palace Inc., EDC Drug Stores Inc., Eckerd Corporation, Edgehill Drugs, Elixir Insurance Company, Elixir Pharmacy LLC, Elixir Rx Options LLC, Elixir Rx Solutions LLC, Elixir Rx Solutions LLC, Elixir Rx Solutions of Nevada LLC, Elixir Savings LLC, Envision Pharmaceutical, Envision Pharmaceutical Holdings LLC, EnvisionRx Puerto Rico Inc., First Florida Insurers of Tampa LLC, GDF Inc., Genovese Drug Stores Inc., Gettysburg and Hoover-Dayton Ohio LLC, Grand River & Fenkell LLC, Harco, Harco Inc., Health Dialog, Health Dialog Services Corporation, Hunter Lane LLC, ILG – 90 B Avenue Lake Oswego LLC, JCG (PJC) USA LLC, JCG Holdings (USA) Inc., K&B Alabama Corporation, K&B Incorporated, K&B Industries, K&B Louisiana Corporation, K&B Mississippi Corporation, K&B Services Incorporated, K&B Tennessee Corporation, K&B Texas Corporation, LMW – 90B Avenue Lake Oswego Inc., Lakehurst and Broadway Corporation, Laker Software LLC, Maxi Drug Inc., Maxi Drug North Inc., Maxi Drug South L.P., Maxi Green Inc., Munson & Andrews LLC, Name Rite LLC, P.J.C. Distribution Inc., P.J.C. Realty Co. Inc., PCS Health Systems, PDS-1 Michigan Inc., PJC Lease Holdings Inc., PJC Manchester Realty LLC, PJC Peterborough Realty LLC, PJC Realty MA Inc., PJC Revere Realty LLC, PJC Special Realty Holdings Inc., PJC of Massachusetts Inc., PJC of Rhode Island Inc., PJC of Vermont Inc., Perry Distributors Inc., Perry Drug Stores Inc., RCMH LLC, RDS Detroit Inc., READ’s Inc., RediClinic, RediClinic Associates Inc., RediClinic LLC, RediClinic US LLC, RediClinic of DC LLC, RediClinic of DE LLC, RediClinic of Dallas Forth-Worth LLC, RediClinic of MD LLC, RediClinic of PA LLC, RediClinic of VA LLC, Richfield Road – Flint Michigan LLC, Rite Aid Drug Palace Inc., Rite Aid Hdqtrs. Corp., Rite Aid Hdqtrs. Funding Inc., Rite Aid Lease Management Company, Rite Aid Online Store Inc., Rite Aid Payroll Management Inc., Rite Aid Realty Corp., Rite Aid Rome Distribution Center Inc., Rite Aid Specialty Pharmacy LLC, Rite Aid Transport Inc., Rite Aid of Connecticut Inc., Rite Aid of Delaware Inc., Rite Aid of Georgia Inc., Rite Aid of Indiana Inc., Rite Aid of Kentucky Inc., Rite Aid of Maine Inc., Rite Aid of Maryland Inc., Rite Aid of Michigan Inc., Rite Aid of New Hampshire Inc., Rite Aid of New Jersey Inc., Rite Aid of New York Inc., Rite Aid of North Carolina Inc., Rite Aid of Ohio Inc., Rite Aid of Pennsylvania LLC, Rite Aid of South Carolina Inc., Rite Aid of Tennessee Inc., Rite Aid of Vermont Inc., Rite Aid of Virginia Inc., Rite Aid of Washington D.C. Inc., Rite Aid of West Virginia Inc., Rite Investments Corp., Rite Investments Corp. LLC, Rx Choice Inc., Rx Initiatives LLC, Rx USA Inc., The Bartell Drug Company, The Jean Coutu Group (PJC) USA Inc., The Lane Drug Company, Thrift Drug Inc., Thrifty Corporation, and Thrifty PayLess Inc..

When was Rite Aid founded?

Rite Aid was founded in 1968.

What is Rite Aid's official website?

The official website for Rite Aid is www.riteaid.com.

How can I contact Rite Aid?

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at (717) 761-2633, via email at [email protected], or via fax at 717-975-5871.

This page was last updated on 5/19/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.